City
Epaper

Study claims ‘Siddha’ drugs combination can reduce anaemia in girls

By IANS | Updated: September 10, 2024 15:25 IST

New Delhi, Sep 10 A combination of Siddha drug treatment can help reduce anaemia among adolescent girls, claims ...

Open in App

New Delhi, Sep 10 A combination of Siddha drug treatment can help reduce anaemia among adolescent girls, claims a study on Tuesday.

The study showed that Siddha drug combination “Annapeticenturam, Bavana katukkay, Matuḷai maṇappaku and Nellikkay lekiyam (ABMN) can improve the level of haemoglobin as well as Packed cell volume (PCV), Mean Corpuscular volume (MCV) and Mean Corpuscular Haemoglobin (MCH) in the anaemic adolescent girls”.

The ABMN medication “significantly lowered the clinical features of anaemia like fatigue, hair loss, headache, loss of interest and menstrual irregularities and significantly improved the level of haemoglobin and PCV, MCV, and MCH in all anaemic girls,” showed the study published in the reputed Indian Journal of Traditional Knowledge (IJTK).

“Siddha medicine plays a notable role in Public Health Initiatives of the Ministry of Ayush. The awareness created among adolescent girls, dietary advice and preventive care provided to them and the treatment through Siddha drugs provided therapeutic benefits to the anaemic patients,” said Dr. R. Meenakumari, Director, National Institute of Siddha, an autonomous body under the Ministry of Ayush.

The study included 2,648 girls, of which 2,300 completed the standard 45-day programme. Reportedly, before the start of the programme, researchers dewormed the participants with Cunṭaivarral curaṇam, and then a 45-day treatment of ABMN was given to all participants under observation.

The team checked for the presence of clinical features like breathlessness, fatigue, giddiness, headache, anorexia, and pallor before and after completion of the programme, along with haemoglobin evaluation and biochemical estimations.

Following the WHO guidelines, the cut-off point for anaemia was set as 11.9 mg/dl, haemoglobin level below 8.0 mg/dl considered as severe, between 8.0 to 10.9 mg/dl as moderate and mild between 11.0 to 11.9 mg/dl.

Further, the team conducted a laboratory investigation for haemoglobin, PCV, MCV, MCH, red blood corpuscles (RBC), platelets, total White blood corpuscles (WBC), neutrophils, lymphocytes and eosinophils in a randomly selected subset of 283 girls.

“Siddha drugs for anaemia can contribute to public health by providing cost-effective and accessible treatment in various settings,” Meenakumari said.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

InternationalPakistan tops Global Terrorism Index amid drop in terrorism deaths worldwide: Report

AurangabadWorker injured; case filed against company officials

AurangabadTributes mark Mahatma Jyotiba Phule Jayanti

InternationalChina-Taliban cooperation sparks outrage from East Turkistan Government in Exile

AurangabadMumbai-bound regular trains on waiting list; weekly summer special announced

Technology Realted Stories

TechnologyMonetary sops, infra push key features of Delhi’s draft EV Policy 2026​

TechnologyHow to Edit Instagram Comments: New Feature, Rules and Time Limit

TechnologyOver 12 lakh 5-kg LPG cylinders sold to students, vulnerable communities since March 23: Centre

TechnologyGas allocation to fertiliser plants enhanced to 95 pc, 4.15 lakh PNG connections gasified: Govt

TechnologyIndia, Saudi Arabia take stock of West Asia situation, to ensure supply chain continuity